IL-33 signalling in liver immune cells enhances drug-induced liver injury and inflammation

ConclusionBlockage of IL-33/ST2 axis reduces APAP-mediated organ injury by dampening liver chemokine release and activation of resident and infiltrating liver non-parenchymal cells.

Source: Inflammation Research - October 14, 2017 Category: Research Source Type: research